Eastern Cooperative Oncology Group (Main Institution)

东部肿瘤合作组（主要机构）

• 批准号: 6780210
• 负责人: John Munn Kirkwood
• 金额: $ 24.15万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 1985
• 资助国家: 美国
• 起止时间: 1985-06-01 至 2006-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6780210
• 关键词: antineoplastics; brain neoplasms; breast neoplasms; cancer prevention; clinical research; combination cancer therapy; combination chemotherapy; cooperative study; gastrointestinal neoplasms; gene therapy; head /neck neoplasm; health behavior; human subject; human therapy evaluation; leukemia; lymphoma; melanoma; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer pharmacology; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; neoplasm /cancer vaccine; oncology; reproductive system neoplasm; tissue resource /registry; urinary tract neoplasms

DESCRIPTION (provided by applicant): This proposal is for support to allow the continued growth and development of the Eastern Cooperative Ontology Group (ECOG) program at the University of Pittsburgh Medical Center (UPMC) and University of Pittsburgh Cancer Institute (UPCI). UPMC and UPCI are strongly committed to the development and clinical evaluation of effective new therapies for cancer. The NCI-designated UPCI comprehensive cancer center has broad basic science strength and depth in a range of multi-modal disease programs that relate closely to ECOG, as its major cooperative group interface. The objectives of the ECOG program at UPCI and the UPMC Cancer Centers are: 1. To increase accrual of patients to ECOG studies at the main institution and its affiliates. 2. To continue to increase scientific participation of the university faculty and affiliate members in ECOG activities, both clinical and laboratory. 3. To further enhance the translation of institutional laboratory science programs related to cancer therapy into ECOG phase II and III studies. 4. To increase the linkage of UPCI resource laboratories such as the Immunologic Monitoring and Cell Processing Laboratory (IMCPL) and therapeutic programs of the ECOG. 5. To maintain and improve the high quality of data submitted for ECOG investigations in terms of completeness, accuracy, and timeliness.

描述（由申请人提供）：本提案旨在支持匹兹堡大学医学中心（UPMC）和匹兹堡大学癌症研究所（UPCI）的东部合作本体组（ECOG）项目的持续增长和发展。UPMC和UPCI坚定地致力于癌症有效新疗法的开发和临床评估。nci指定的UPCI综合癌症中心在与ECOG密切相关的一系列多模式疾病项目中具有广泛的基础科学实力和深度，是其主要的合作组接口。UPCI和UPMC癌症中心ECOG项目的目标是：